DB05841ExperimentalSmall molecule
AI-128 is the first human demonstration of sustained release drug administration in the lung. AI-128 consists of slowly dissolving microspheres designed to control where drug particles go in the lung...
- Primary indication
- Investigated for use/treatment in asthma.Curator reviewed
- Code names
- AI-128
Which companies are running trials of AI-128, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account